Total Funding
84
60
Total FundingSeries B raised
Growth Score
-8 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17878
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
- Theodore Randolph: Co-founder and CTO
- Robert Garcea: Co-Founder and CSO
About the Company
VitriVax is a formulation technology company that develops solutions to enhance the global distribution and effectiveness of human vaccines. The company's core technology, Atomic Layering Thermostable Antigen and Adjuvant platform, addresses two major logistical barriers in vaccination. This platform eliminates the need for a cold chain by
making vaccines thermostable, allowing them to be stored and transported at ambient temperatures up to 70°C for months.
